AHR and hepatocellular carcinoma: We previously observed that suppression of the AHR levels after down-regulation of p23 in Hepa1c1c7 mouse hepatoma cells was caused by increased AHR degradation, which could not be reversed by the treatment of a proteasome inhibitor MG132 [15].